JPRN-UMIN000048313已完成未知
Evaluation of effects of alcohol - Evaluation of effects of alcohol
TT DATA INSTITUTE OF MANAGEMENT CONSULTING, Inc.0 个研究点目标入组 90 人开始时间: 2022年7月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 35years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1. Those who have history of alcoholism or other mental or neurological problems 2. Those who has a problem with wearing heart rate meters 3. Those who has difficulty abstaining from alcohol starting from one day prior to the start of the study 4. Those who is unable to drink alcohol constitutionally 5. Judged by the investigator to be unsuitable for participating in this study
研究者
相似试验
已完成
2 期
Evaluation of the occurrence, effect and side effects oFcyclophosfamid and rituximab in the tratment of children with NEPHROTIC SYNDROM resistance to STEROID that referred to Hazrate Massumeh hospital .IRCT20170527034146N2Ghoum University of Medical Sciences102
已完成
不适用
Assessment on no observed adverse effect level of the test food (HBF2019-01) for loose stoolsHealthy adultJPRN-UMIN000037115Hayashibara Co., Ltd.20
尚未招募
1 期
â??understand the quality of colostomy care video teaching on Knowledge and practice regarding colostomy care among parents or who are giving care to colostomy child in department of pediatric surgery Sanjay Gandhi Post Graduation Institute Of Medical Sciences Lucknow UPâ??CTRI/2018/01/011070nil
已完成
不适用
The evaluation of subsicion in the correction of nasolabial fold depthasolabial fold.Other atrophic disorders of skinIRCT201705278146N19Vice chancellor for research,Shahid Beheshti University of Medical Sciences10
招募中
不适用
Tolerated dose of Lomustine used in combination with Etoposide and Cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patientsThe participants are patients with lymphoma (Hodgkin's disease and NonHodgkins lymphoma) who are chemosensitive and have indication for hematopoietic stem cell transplantation (as refractoriness) - thus, they will be submitted to this new protocol (LEC-Lomustine, Etoposide and Cyclophosphamide) with evaluation of the maximum tolerated dose of Lomustine.Descriptors: Hodgkins LymphomaNonhodgkins LymphomaM9590/3RBR-10bj7s98niversidade Federal de Juiz de Fora